Table 1.
Tissue levels of serotonin, 5-HIAA and serotonin turnover rates (5-HIAA:serotonin) 30 min after 5-HTP (80 mg/kg) or its vehicle in SERT +/+, +/− and −/− mice.
Measurement (pg/mg tissue) Brain area
|
Drug condition | Two-way ANOVA | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Vehicle
|
5-HTP
|
Genotype
|
Drug condition
|
Interaction
|
||||||||
SERT +/+
|
SERT +/−
|
SERT −/−
|
SERT +/+
|
SERT +/−
|
SERT −/−
|
F2,31 |
p-value
|
F1,31 |
p-value
|
F2,31 |
p-value
|
|
Serotonin | ||||||||||||
Brain stem | 961 ± 22 | 976 ± 62 | 284 ± 54#### | 2498 ± 252 | 2611 ± 205 | 1922 ± 265 | 57.59 | < 0.0001 | 769.63 | < 0.0001 | 0.33 | NS |
Frontal cortex | 763 ± 55 | 811 ± 65 | 243 ± 14#### | 1595 ± 214 | 1600 ± 197 | 1071 ± 56 | 70.22 | < 0.0001 | 370.86 | < 0.0001 | 0.12 | NS |
Hippocampus | 780 ± 67 | 741 ± 92 | 247 ± 32#### | 2024 ±515 | 2005 ± 288 | 1432 ± 223 | 17.59 | < 0.0001 | 202.08 | < 0.0001 | 0.07 | NS |
Hypothalamus | 1799 ± 199 | 1790 ± 225 | 580 ± 144#### | 5237 ± 628 | 5251 ± 446 | 3688 ± 322 | 56.88 | < 0.0001 | 751.03 | < 0.0001 | 0.87 | NS |
Striatum | 715 ± 50 | 737 ± 106 | 307 ± 109#### | 3505 ± 399 | 3771 ± 647 | 3579 ± 498 | 2.00 | NS (0.15) | 561.97 | < 0.0001 | 1.15 | NS |
5-HIAA | ||||||||||||
Brain stem | 884 ± 168 | 591 ± 162 | 508 ± 133 | 5292 ± 563 | 5645 ± 496 | 5070 ± 622 | 2.34 | NS (0.11) | 1165.88 | < 0.0001 | 2.07 | NS |
Frontal cortex | 385 ± 97 | 292 ± 84 | 221 ± 62 | 3209 ± 277 | 3132 ± 447 | 2713 ± 171 | 5.99 | 0.006 | 1153.74 | < 0.0001 | 1.98 | NS |
Hippocampus | 795 ± 191 | 512 ±129 | 618 ±534 | 4172 ± 351 | 4081 ± 384 | 3617 ± 331 | 3.33 | 0.049 | 839.53 | < 0.0001 | 2.15 | NS |
Hypothalamus | 999 ± 209 | 675 ± 233 | 600 ± 174 | 7236 ± 1055 | 7110 ± 746 | 6370 ± 571 | 3.43 | 0.045 | 966.50 | < 0.0001 | 1.00 | NS |
Striatum | 589 ± 223 | 483 ± 125 | 417 ± 171 | 5512 ±449 | 5713 ± 313 | 5269 ± 680 | 1.59 | NS | 1630.89 | < 0.0001 | 0.9 | NS |
Serotonin turnover | ||||||||||||
Brain stem | 92 ± 16 | 60 ± 14 | 178 ± 31**** | 212 ± 17++++ | 216 ± 13++++ | 264 ± 11++++**** | 73.12 | < 0.0001 | 407.19 | < 0.0001 | 11.63 | < 0.0001 |
Frontal cortex | 51 ± 13 | 36 ± 8 | 90 ± 22 | 203 ± 19 | 196 ± 12 | 254 ± 20 | 40.82 | < 0.0001 | 869.76 | < 0.0001 | 0.38 | NS |
Hippocampus | 101 ± 20 | 68 ± 10 | 244 ± 194 | 214 ±42 | 208 ± 38 | 259 ± 50 | 6.28 | 0.005 | 10.25 | 0.003 | 1.85 | NS |
Hypothalamus | 55 ± 9 | 37 ± 9 | 103 ± 17**** | 138 ± 10++++ | 135 ± 5++++ | 173 ± 9++++**** | 84.38 | < 0.0001 | 588.16 | < 0.0001 | 5.75 | 0.008 |
Striatum | 83 ± 33 | 65 ± 11 | 134 ± 23** | 159 ± 20++ | 155 ± 24++++ | 148 ± 17 | 6.18 | 0.006 | 65.32 | < 0.0001 | 9.85 | < 0.0001 |
Data represent the mean ± SEM. NS, not significant.
p < 0.0001 compared to SERT +/+ mice in the same drug condition, based on pre-planned comparisons (Tukey post hoc tests) to confirm previous findings (Kim et al. 2005);
p < 0.01
p < 0.0001 compared to SERT +/+ mice in the same drug condition
p < 0.01
p < 0.0001 compared to vehicle-treated mice of the same genotype (Tukey post hoc tests for significant interactions).